Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Excessive Sleepiness Clinical Trial

Official title:
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Armodafinil Treatment (150 mg) in Improving Clinical Condition Late in the Shift and in Improving Functional and Patient-Reported Outcomes in Adult Patients With Excessive Sleepiness Associated With Shift Work Disorder

Status Completed

Clinical Trial Summary

The primary objective of the study is to determine whether armodafinil treatment is more effective than placebo treatment in patients with excessive sleepiness associated with shift work disorder (SWD) by measuring improved clinical condition late in the shift, including the commute home.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Disorders of Excessive Somnolence
Excessive Sleepiness

Clinical Trial Details

NCT number	NCT01080807
Study type	Interventional
Source	Teva Pharmaceutical Industries
Contact
Status	Completed
Phase	Phase 4
Start date	March 2010
Completion date	October 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01766323` - Palliative Morphine With or Without Concurrent Modafinil	Phase 3
Completed	`NCT00758498` - Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder	Phase 3
Completed	`NCT00711516` - Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance	Phase 4
Completed	`NCT00174174` - Provigil (Modafinil) Study by Taiwan Biotech Co.	N/A
Terminated	`NCT04618263` - Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers	Phase 1
Completed	`NCT00080288` - Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD	Phase 3
Completed	`NCT02806908` - Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy	Phase 2
Completed	`NCT02806895` - Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA	Phase 2
Recruiting	`NCT04788953` - Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder	Phase 4
Completed	`NCT03881852` - Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)	Phase 2
Completed	`NCT03037203` - A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness	Phase 2
Completed	`NCT05008341` - Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration	Phase 1